Reiki in Symptom Management of Hemodialysis Patients

Not Applicable

Completed

• Conditions: Renal Dialysis
• Interventions: Other: Reiki

• Registration Number: NCT05833451
• Lead Sponsor: Osmaniye Korkut Ata University

Brief Summary

This study aims to investigate the effect of Reiki applied to individuals receiving hemodialysis treatment on hemodialysis-related symptoms and hematological indicators.

Detailed Description

The study has a pretest-posttest randomized controlled design and it was carried out between March and July 2022 with 64 patients over the age of 18 who received hemodialysis treatment for at least 15 days in the dialysis unit of state hospitals in two different cities. Data were collected using the Patient Information Form, the Dialysis Symptom Index (DSI), and the follow-up chart including erythrocyte (RBC), hemoglobin (HGB), hematocrit (HCT), serum urea, creatinine, sodium (Na), potassium (K), phosphorus (P), and calcium (Ca) values. While the distance Reiki intervention was applied to each of the patients in the Reiki group for 60 minutes, no intervention was made in the control group. One week after the intervention, the DSI was re-administered to the patients in the posttest, and hematology and biochemistry results were recorded.

Study Timeline

• Study Start: 2022-03-07
• Primary Completion: 2022-06-13
• Study Completion: 2022-07-08
• Study First Submitted: 2023-03-29
• Status Verified: 2023-04
• Study First Submitted QC: 2023-04-25
• Last Update Submitted: 2023-04-25
• Study First Posted: 2023-04-27
• Last Update Posted: 2023-04-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 64

Inclusion Criteria

• To be over 18 years of age,
• To have received hemodialysis treatment for at least 15 days,
• To volunteer to participate in the study,
• To be able to answer the given forms and questionnaires

Read More

Exclusion Criteria

• To be a Reiki practitioner or trainer,
• To have attended any energy therapy session before,
• Using other complementary and integrative medicine practices at the time of the application.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Reiki	Reiki	The participants in the Reiki group (n=32) were given Reiki remotely for 60 minutes by two certified practitioners who completed the second level Reiki training with a Master degree Reiki instructor according to the Usui method.

Primary Outcome Measures

Name	Time	Method
Change from baseline Dialysis Symptom Index at a week	Within 1 hour of first admission. -A week later	The Dialysis Symptom Index was used to investigate the therapeutic effect of Reiki on hemodialysis-related symptoms. The index consists of 30 items to evaluate physical and emotional symptoms and the severity of these symptoms. Participants are asked to define the presence of each symptom they experienced in the last week as Yes or No, and they are also report how much symptoms they experience affect them on a five-point Likert type scale (1 = not at all bothersome, 5 = very much bothersome). The lowest score to be obtained from the index is 0, the highest score is 150, and higher scores indicate more dialysis symptoms. In order to reach the Primary Outcome Measure, it was aimed that the Dialysis Symptom Index total scores of the individuals in the intervention group were lower in the final measurement than in the first measurement.

Secondary Outcome Measures

Name	Time	Method
Change from Sodium values at a week	Within one week of first application	In this section there is Sodium value required for eliminating fluid-electrolyte imbalances. The observed sodium is expected to be 136 -144 mmol/L.
Change from Potassium values at a week	Within one week of first application	In this section there is Potassium value required for eliminating fluid-electrolyte imbalances. The observed sodium is expected to be 3.7 - 5.1 mmol/L
Change from urea values at a week	Within one week of first application	In this section there is urea value required for eliminating fluid-electrolyte imbalances. The observed urea is expected to be 1.8 to 7.1 mmol
Change from Chloride values at a week	Within one week of first application	In this section there is Chloride value required for eliminating fluid-electrolyte imbalances. The observed Chloride is expected to be 97 - 105 mmol/L
Change from Magnesium values at a week	Within one week of first application	In this section there is Magnesium value required for eliminating fluid-electrolyte imbalances. The observed Magnesium is expected to be 1.7- 2.2 mg/dL
Change from Hemoglobin values at a week	Within one week of first application	In this section there is Hemoglobin value required for preventing anemia. The observed Hemoglobin is expected to be Male (ages 15+): 13.0 - 17.0 g/dL; Female (ages 15+): 11.5 - 15.5 g/dL
Change from Calcium values at a week	Within one week of first application	In this section there is Calcium value required for eliminating fluid-electrolyte imbalances. The observed Calcium is expected to be 8.5 -10.2 mg/dL
Change from Phosphate values at a week	Within one week of first application	In this section there is Phosphate value required for eliminating fluid-electrolyte imbalances. The observed Phosphate is expected to be 2.5- 4.8 mg/dL
Change from Hematocrit values at a week	Within one week of first application	This section contains the Hematocrit value, which should be in the appropriate range to prevent fluid imbalance and anemia. The observed Hematocrit is expected to be Male: 40 - 55%; Female: 36 - 48%

Trial Locations

Locations (1)

Osmaniye Korkut Ata University; 🇹🇷 Osmaniye, Turkey